International Finance Facility for Immunisation: building a financial lifeline from the world’s investors to its poorest children
Every year, 19 million children miss out on vaccines against common diseases. 1.7 million die from easily-preventable diseases
Shortage of secure, predictable funding stops developing countries planning long-term health programmes for their children
IFFIm was set-up in 2006 to accelerate the availability and predictability of funds for immunisation programmes
IFFIm raises finance by issuing 'vaccine bonds' in capital markets, converting long-term government pledges into immediate cash
UK, France, Italy, Norway, Australia, Spain, the Netherlands, Sweden, South Africa have committed US$ 6.3 billion to IFFIm over 23 years
IFFIm funds help the Global Alliance for Vaccines and Immunisation. In 12 years, GAVI has prevented over 5.5 million future deaths
IFFIm funds catalyse uptake of vaccines against diphtheria, tetanus, pertussis, hepatitis B, Haemophilus influenzae type b
IFFIm funds strengthen immunisation and health service delivery through health worker training and support for cold chain and logistics
IFFIm supports polio and yellow fever vaccines, measles mortality reduction, maternal & neonatal tetanus
Thanks to IFFIm, GAVI has been able to nearly double its support for vaccine introduction in developing countries since 2006
Welcome to the new IFFIm website with easier to find content, case studies of IFFIm’s real-life impact on immunisation and an improved library section.
22 April 2013FitchRatings action
5 March 2013Moody’s Investors Service rating action
20 December 2012Moody's 2012 credit analysis
17 December 2012Standard & Poor’s research update
IFFIm press releases
Learn more about IFFIm
How the capital markets can save livesRené Karsenti’s view of IFFIm’s role
Learn how IFFIm has played a critical role in polio eradication with a US$ 191 million investment.
US$ 1.2 billion for GAVI-eligible countries has increased global uptake of new & underused vaccines.
Download presentation on IFFIm
IFFIm: the challenge, the solution, the results
Read the June 2011 IFFIm Evaluation documents
The GAVI Alliance was set-up in 2000 to save children's lives and
protect people's health by increasing access to immunisation in
US$ 2.2 billion of disbursements have nearly doubled expenditures on health for the GAVI Alliance.
To date, nine donors have pledged US$ 6.3 billion to IFFIm over 23 years.
28 March 2013
IFFIm Vaccine Bonds for Japanese Investors
Daiwa Securities Group, the International Finance Facility for Immunisation (IFFIm), the GAVI Alliance and the World Bank jointly announce the first issuance and sale of “vaccine bonds” for 2013.
06 March 2013
IFFIm rating action by Moody’s follows UK downgrade
Moody’s Investors Service downgrades the International Finance Facility for Immunisation Company (IFFIm) by one notch from Aaa to Aa1 and maintains a negative outlook.
01 March 2013
IFFIm honoured by editors as capital market's 'SRI Innovation of the Decade'
IFFIm cited as the “SRI Innovation of the Decade” by mtn-i, an online and print publisher that covers the medium-term note market.
Download IFFIm Update no.7
12 October 2012
Appeal for Vaccine Bonds
11 January 2012
Advancing the Global Health Agenda
09 December 2011
The art of making vaccines more affordable - Seth Berkley
Global Health Magazine
05 December 2011
The Intersection of Innovative Financing and Global Health
Japan International Cooperation Agency to issue bonds to investors
17 November 2011
Green light from GAVI for cervical cancer vaccine
02 October 2011
Making money in pursuit of social good
27 September 2011
Gates-Backed Alliance To Prevent Pneumonia, Diarrhea In Children
20 September 2011
Poor Countries Lead in Mother, Child Spending
The New York Times
25 August 2011
Impact investing: Harbinger of A Brighter Future and A Friendlier Bond Market?
Forbes India Magazine
© IFFIm 2013
modal window here